A new study from The Lancet revealed that three-quarters of U.S. adults and almost half of teens are now overweight or obese. Weight loss drugs like Ozempic, Wegovy, and Mounjaro, known as GLP-1 drugs, have been making headlines as effective treatments that are in high demand. But should they be available to anyone who wants them or only when medically indicated? Those who believe they should be broadly available say they can increase self-esteem and are an important tool for those unable to lose weight through lifestyle changes alone. They also say they may reduce the risks of diabetes, heart disease, and joint issues and point to new research that suggests the drugs might help with improving cardiovascular and brain health and reduce the risk of conditions such as Alzheimer’s disease.Others argue that weight loss drugs are notright for everyone andcaution againstliberal access, citing bothknown side effects and unknown long-term effects. They also worry about what could happen if people take them without medical supervision and raise equity issues, given the high cost of the drugs. With this background, we debate whether prescription weight loss drugs should be available for all.
After the October 7th attack, Israel vowed to eradicate Hamas and began its counteroperation in Gaza. Now, after ten months of war, a hostage crisis, and an increasing death toll, Israel and Hamas have been…
Donald Trump is the first former president to be convicted of a crime. He was found guilty of 34 felony counts of falsifying business records in the first degree under New York law. Trump has…
The Supreme Court is taking up a case that could affect how you read about issues during a crucial election year. Government officials concerned about misinformation related to topics such as COVID and election integrity…
Since the beginning of Russia’s invasion of Ukraine, the United States has provided more than $75 billion in aid to Ukraine, which has been directed toward military operations, economic support, and humanitarian assistance. As the…
Post-October 7th, Iran's presence in the Middle East—and on the world stage—is growing stronger, many say, given its nuclear ambitions and its use of proxies in Gaza, Syria, Lebanon, and Yemen, most recently disrupting shipping…
In a new “Mock Trial” debate format, Open to Debate will take on the most important legal questions of our time, with each episode focusing on a high-profile case unfolding in the public square. We’ll…
A new study from The Lancet revealed that three-quarters of U.S. adults and almost half of teens are now overweight or obese. Weight loss drugs like Ozempic, Wegovy, and Mounjaro, known as GLP-1 drugs, have been making headlines as effective treatments that are in high demand. But should they be available to anyone who wants them or only when medically indicated? Those who believe they should be broadly available say they can increase self-esteem and are an important tool for those unable to lose…
A new study from The Lancet revealed that three-quarters of U.S. adults and almost half of teens are now overweight or obese. Weight loss drugs like Ozempic, Wegovy, and Mounjaro, known as GLP-1 drugs, have been making headlines as…
The Hopkins Forum, a new nonpartisan debate series from Johns Hopkins University and Open to Debate, is hosting its first debate and taking a close look at the highest court in the land and its future. In the past year, multiple proposals have been suggested to change the way the Supreme Court operates. While the Justices enjoy lifetime tenure, term limits have been discussed in policy circles as a way to bring fresh and diverse perspectives to the bench. Others have suggested similar objectives might be achieved…
The Hopkins Forum, a new nonpartisan debate series from Johns Hopkins University and Open to Debate, is hosting its first debate and taking a close look at the highest court in the land and its future. In the past…